ANGLE PLC’s (OTCMKTS:ANPCY, LON:AGL) Parsortix device will be the focus of a poster presentation at the American Association for Clinical Chemistry (AACC) annual meeting later today.
Posters are used at large conventions such as the AACC to showcase discoveries or developments.
In the case of ANGLE it will be used to demonstrate Parsortix’s ability to harvest breast cancer cells for subsequent gene expression analysis.
The presentation is based around the pioneering work of James Reuben, a professor at the University of Texas MD Anderson Cancer Center.
According to ANGLE chief technology officer, Shane Booth, gene expression analysis could prove a “very important” new diagnostic tool.